GSK – GlaxoSmithKline plc

GSK plc

GSK

$55.83

Name : GSK plc

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $112,445,063,168.00

EPSttm : 3.68

GSK plc

$55.83

1.15%

$0.635

GSK — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

0.62

Margin Of Safety %

Put/Call OI Ratio

0.54

EPS Next Q Diff

0.55

EPS Last/This Y

0.96

EPS This/Next Y

0.36

Price

55.17

Target Price

56.87

Analyst Recom

2.57

Performance Q

12.38

Upside

45.9%

Beta

0.49

Ticker: GSK

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-02	GSK	58.28	0.94	0.27	57775
2026-03-04	GSK	56.83	0.91	1.60	59944
2026-03-05	GSK	55.26	0.97	0.53	62593
2026-03-09	GSK	55.49	0.84	0.42	62989
2026-03-10	GSK	55.33	0.84	2.28	63468
2026-03-11	GSK	55.15	0.89	5.15	65518
2026-03-12	GSK	54.29	0.91	0.33	66169
2026-03-17	GSK	53.39	0.86	0.57	64611
2026-03-18	GSK	52.08	0.85	0.14	65099
2026-03-19	GSK	52.38	0.80	1.19	67441
2026-03-20	GSK	51.83	0.75	0.47	65553
2026-03-23	GSK	51.99	0.67	0.25	58734
2026-03-24	GSK	52.94	0.67	0.12	59357
2026-03-25	GSK	54.71	0.56	0.88	67030
2026-03-26	GSK	53.95	0.57	0.23	67606
2026-03-27	GSK	53.84	0.57	1.16	67827
2026-03-30	GSK	54.2	0.57	0.05	67581
2026-03-31	GSK	55.17	0.54	0.81	69907
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-02	GSK	58.28	-3.9	2608.7	4.75
2026-03-03	GSK	57.08	-3.9	2423.1	4.75
2026-03-04	GSK	56.82	-3.9	2669.4	4.75
2026-03-05	GSK	55.26	-3.9	2400.3	4.77
2026-03-06	GSK	54.51	-3.9	2558.3	4.77
2026-03-09	GSK	55.49	-3.9	2874.7	4.77
2026-03-10	GSK	55.33	-3.9	2238.1	4.77
2026-03-11	GSK	55.16	-3.9	1727.5	4.77
2026-03-12	GSK	54.29	-3.9	1547.8	4.77
2026-03-13	GSK	53.39	-3.9	1552.5	4.77
2026-03-17	GSK	53.40	-3.9	1747.6	4.77
2026-03-18	GSK	52.07	-3.9	1547.8	4.77
2026-03-19	GSK	52.38	-3.9	1829.0	4.77
2026-03-20	GSK	51.83	-3.9	1887.6	4.77
2026-03-23	GSK	51.99	-3.9	1950.5	4.77
2026-03-24	GSK	52.95	-3.9	2165.7	4.77
2026-03-25	GSK	54.71	-3.9	2016.3	4.77
2026-03-26	GSK	53.98	-3.9	1463.7	4.77
2026-03-27	GSK	53.83	-3.9	1470.4	4.77
2026-03-30	GSK	54.24	-3.9	1539.7	4.77
2026-03-31	GSK	55.17	-3.9	1648.5	4.77
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-02	GSK	0	-2.87	0.65
2026-03-03	GSK	0	-2.87	0.65
2026-03-04	GSK	0	-2.87	0.65
2026-03-05	GSK	0	-2.87	0.65
2026-03-06	GSK	0	-2.87	0.65
2026-03-09	GSK	0	-2.87	0.65
2026-03-10	GSK	0	-2.87	0.65
2026-03-11	GSK	0	-2.87	0.54
2026-03-12	GSK	0	-2.87	0.54
2026-03-13	GSK	0	-2.87	0.54
2026-03-17	GSK	0	-2.82	0.54
2026-03-18	GSK	0	-2.82	0.54
2026-03-19	GSK	0	-2.82	0.54
2026-03-20	GSK	0	-2.82	0.54
2026-03-23	GSK	0	-2.90	0.54
2026-03-24	GSK	0	-2.90	0.54
2026-03-25	GSK	0	-2.90	0.62
2026-03-26	GSK	0	-2.90	0.62
2026-03-27	GSK	0	-2.90	0.62
2026-03-30	GSK	0	-3.37	0.62
2026-03-31	GSK	0	-3.37	0.62
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.68

Avg. EPS Est. Current Quarter

1.16

Avg. EPS Est. Next Quarter

1.23

Insider Transactions

Institutional Transactions

-3.37

Beta

0.49

Average Sales Estimate Current Quarter

7656

Average Sales Estimate Next Quarter

8300

Fair Value

63.88

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

10.6

Max Drawdown 5-Year %

-39.3

Target Price

56.87

P/E

15.06

Forward P/E

10.41

PEG

1.85

P/S

2.56

P/B

5.03

P/Free Cash Flow

14.01

EPS

3.66

Average EPS Est. Cur. Y

4.77

EPS Next Y. (Est.)

5.13

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.47

Relative Volume

Return on Equity vs Sector %

7.5

Return on Equity vs Industry %

-1.6

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

1648.5

◆ GSK Healthcare

$55.19

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

8/20

Pullback

17/25

Volume

4/15

Valuation

10/20

TP/AR

2/10

Options

5/10

RSI

53.5

Range 1M

44.6%

Sup Dist

2.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

12/30

Estimates

8/20

Inst/Vol

4/15

Options

6/10

EPS Yr

2.3%

EPS NY

10.3%

52W%

76.5%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +57.6% upside

Quality

27/30

Valuation

18/30

Growth

12/25

Stability

2/10

LT Trend

3/5

Upside

+57.6%

Quality

MoS

16%

GSK plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 66841

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

GSK

Latest News

—

Caricamento notizie per GSK…

stock quote shares GSK – GlaxoSmithKline plc Stock Price stock today

news today GSK – GlaxoSmithKline plc stock forecast ,stock prediction 2023 2024 2025

marketwatch GSK – GlaxoSmithKline plc yahoo finance google finance

stock history GSK – GlaxoSmithKline plc invest stock market

stock prices GSK premarket after hours

ticker GSK fair value insiders trading

GSK – GlaxoSmithKline plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: GSK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y